E-LIB Suche - Ergebnisse für: Proia, L.

1

CFT7455, a novel IKZF1/3 degrader, demonstrates potent acti..:

Thomenius, M. J. ; Perino, S. ; Kirby, J....
Hematological Oncology. 41 (2023) S2 - p. 550-551 , 2023

Link: https://doi.org/10.1002/..

2

C50 CARDIO–ONCO–HAEMATOLOGY IN CLINICAL PRACTICE. A "CHANGE..:

Bisceglia, I ; Mistrulli, R ; Cartoni, D...
European Heart Journal Supplements. 24 (2022) Supplement_C - p. , 2022

Link: https://doi.org/10.1093/..

3

CFT7455: A NOVEL, IKZF1/3 DEGRADER THAT DEMONSTRATES POTENT..:

Perino, S ; Class, B ; Henderson, C...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

4

Interaction between Physical Heterogeneity and Microbial Pr..:

Perujo, N. ; Sanchez-Vila, X. ; Proia, L..
Environmental Science & Technology. 51 (2017) 11 - p. 6110-6119 , 2017

Link: https://doi.org/10.1021/..

5

Biodegradation kinetics of dissolved organic matter chromat..:

Catalán, N. ; Casas-Ruiz, J. P. ; von Schiller, D....
Journal of Geophysical Research: Biogeosciences. 122 (2017) 1 - p. 131-144 , 2017

Link: https://doi.org/10.1002/..

6

Microbial carbon processing along a river discontinuum:

Proia, L. ; von Schiller, D. ; Gutierrez, C....
Freshwater Science. 35 (2016) 4 - p. 1133-1147 , 2016

Link: https://www.jstor.org/st..

7

Improving survival by exploiting tumour dependence on stabi..:

Alexandrova, E. M. ; Yallowitz, A. R. ; Li, D....
Nature. 523 (2015) 7560 - p. 352-356 , 2015

Link: https://doi.org/10.1038/..

8

Resistance to HSP90 inhibition involving loss of MCL1 addic..:

Busacca, S ; Law, E W P ; Powley, I R...
Oncogene. 35 (2015) 12 - p. 1483-1492 , 2015

Link: https://doi.org/10.1038/..

9

Erratum: Corrigendum: Improving survival by exploiting tumo..:

Alexandrova, E. M. ; Yallowitz, A. R. ; Li, D....
Nature. 527 (2015) 7578 - p. 398-398 , 2015

Link: https://doi.org/10.1038/..

10

Preclinical Testing Demonstrates Striking Efficacy of STA-1..:

Boumber, Y. ; Gaponova, A. ; Nikonova, A.S....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S64-S65 , 2014

Link: https://doi.org/10.1016/..

11

Human mesenchymal stromal cells primed with paclitaxel, apa..:

Starc, N. ; Conforti, A. ; Biagini, S....
Cytotherapy. 16 (2014) 4 - p. S69 , 2014

Link: https://doi.org/10.1016/..

12

UDP glucuronosyltransferase 1A expression levels determine ..:

Landmann, H ; Proia, D A ; He, S...
Cell Death & Disease. 5 (2014) 9 - p. e1411-e1411 , 2014

Link: https://doi.org/10.1038/..

13

Phenotypical and functional characterization of mesenchymal..:

Starc, N. ; Conforti, A. ; Taranta, A....
Cytotherapy. 16 (2014) 4 - p. S79 , 2014

Link: https://doi.org/10.1016/..

14

847: Hsp90 inhibitor–drug conjugates (HDCs): concept and pr..:

Ying, W. ; Chimmanamada, D. ; Przewloka, T....
European Journal of Cancer. 50 (2014) - p. S206 , 2014

Link: https://doi.org/10.1016/..

15

Characterization of the in vitro immunomodulatory propertie..:

Conforti, A. ; Scarsella, M. ; Giorda, E....
Cytotherapy. 16 (2014) 4 - p. S69 , 2014

Link: https://doi.org/10.1016/..